Encompass Health (EHC) SVP sells 11,937 shares, gifts 3,000

Rhea-AI Filing Summary

Encompass Health Corp senior vice president and treasurer Edmund Fay reported an open-market sale and a charitable gift of company stock. On March 9, 2026, he sold 11,937 shares of Encompass Health common stock at $107 per share, then donated 3,000 shares as a bona fide gift to a donor advised fund administered by Schwab. After these transactions, Fay directly holds 86,325 shares of Encompass Health common stock, indicating he retains a substantial equity stake in the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fay Edmund

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. Vice Pres. and Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	03/09/2026		S		11,937	D	$107	89,325	D
Encompass Health Common Stock	03/09/2026		G(1)		3,000	D	$0	86,325	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock that the reporting person donated as a gift to a donor advised fund administered by Schwab.

	/s/ Edmund Fay	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Edmund Fay report for Encompass Health (EHC)?

Edmund Fay reported two transactions in Encompass Health common stock: an open-market sale of 11,937 shares at $107 per share and a separate disposition of 3,000 shares as a bona fide gift to a donor advised fund administered by Schwab.

How many Encompass Health (EHC) shares did Edmund Fay sell and at what price?

Edmund Fay sold 11,937 shares of Encompass Health common stock in an open-market transaction at $107 per share. This sale was reported as a non-derivative transaction and categorized as an open-market sale under the Form 4 filing.

What was the nature of the 3,000-share transfer by Edmund Fay in Encompass Health (EHC)?

The 3,000-share transfer was reported as a bona fide gift. The filing notes that Fay donated 3,000 shares of Encompass Health common stock to a donor advised fund administered by Schwab, meaning he received no sale proceeds from this specific disposition.

How many Encompass Health (EHC) shares does Edmund Fay hold after these transactions?

Following the reported sale and gift, Edmund Fay directly holds 86,325 shares of Encompass Health common stock. This post-transaction balance reflects both the 11,937 shares sold and the 3,000 shares donated as a gift on March 9, 2026.

What roles and positions does Edmund Fay hold at Encompass Health (EHC)?

Edmund Fay is identified as an officer of Encompass Health Corp, serving as senior vice president and treasurer. He is not reported as a director or a ten percent owner in this Form 4, but he remains a significant company insider.

Were any derivative securities involved in Edmund Fay’s Encompass Health (EHC) Form 4?

No derivative securities were reported in this Form 4. All disclosed transactions involve Encompass Health common stock as non-derivative securities, and the derivative summary section shows no remaining derivative positions or option exercises for this filing.